Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

× No keyword cloud information.

16 in total

1. EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer.

Authors: David E Gerber
Journal: Drug Dev Res Date: 2008-12-09 Impact factor: 4.360

2. Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer.

Authors: Qianping Li; Weijie Ma; Tianhong Li
Journal: J Thorac Dis Date: 2018-09 Impact factor: 2.895

3. Treatment of cancer patients in their last month of life: aimless chemotherapy.

Authors: Tarek Assi; Elie El Rassy; Samer Tabchi; Toni Ibrahim; Tania Moussa; Ralph Chebib; Fadi El Karak; Fadi Farhat; Georges Chahine; Fadi Nasr; Marwan Ghosn; Joseph Kattan
Journal: Support Care Cancer Date: 2015-09-21 Impact factor: 3.603

4. Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period.

Authors: David M McClatchy; Henning Willers; Aaron N Hata; Zofia Piotrowska; Lecia V Sequist; Harald Paganetti; Clemens Grassberger
Journal: Cancer Res Date: 2020-09-09 Impact factor: 12.701

5. Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians.

Authors: Yongsheng Wang; Gerald Schmid-Bindert; Caicun Zhou
Journal: Ther Adv Med Oncol Date: 2012-01 Impact factor: 8.168

6. Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.

Authors: Tianhong Li; Bilal Piperdi; William V Walsh; Mimi Kim; Laurel A Beckett; Rasim Gucalp; Missak Haigentz; Venu G Bathini; Huiyu Wen; Kaili Zhou; Patricia B Pasquinelli; Srikanth Gajavelli; Meera Sreedhara; Xianhong Xie; Primo N Lara; David R Gandara; Roman Perez-Soler
Journal: Clin Lung Cancer Date: 2016-10-28 Impact factor: 4.785

7. Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of published randomized trials.

Authors: Ezzeldin M Ibrahim
Journal: Ann Thorac Med Date: 2010-07 Impact factor: 2.219

8. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.

Authors: Fred R Hirsch; Roy S Herbst; Christine Olsen; Kari Chansky; John Crowley; Karen Kelly; Wilbur A Franklin; Paul A Bunn; Marileila Varella-Garcia; David R Gandara
Journal: J Clin Oncol Date: 2008-07-10 Impact factor: 44.544

Review 9. The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.

Authors: Zarnie Lwin; Jonathan W Riess; David Gandara
Journal: J Thorac Dis Date: 2013-10 Impact factor: 2.895

10. Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib.

Authors: Hua Cheng; She-Juan An; Song Dong; Yi-Fang Zhang; Xu-Chao Zhang; Zhi-Hong Chen; Yi-Long Wu
Journal: J Hematol Oncol Date: 2011-01-21 Impact factor: 17.388